BASF refocus plant biotech R&D; cuts 350 jobs, closes sites

BASF to refocus plant biotech R&D; cuts 350 jobs, closes sites

8:59 AM, 26th February 2016
BASF to refocus plant biotech R&D; cuts 350 jobs, closes sites

LUDWIGSHAFEN, GERMANY: BASF SE said that it is refocusing its plant biotechnology research portfolio and will restructure its plant science operations, as part of its regular portfolio review.

The company will adjust the site footprint of its plant biotechnology research and development network in North America and Europe and intends to reduce approximately 350 positions, thereof 140 positions in North America and 180 in Europe. Currently approximately 700 employees work in plant biotechnology R&D.

Research and field sites in Research Triangle Park (North Carolina); Ames (Iowa); Berlin and Limburgerhof (Germany); Ghent (Belgium) and Brazil will be kept but are planned to be reduced in size. The field testing sites in Kekaha, Hawaii, as well as the sites in India and Puerto Rico will be closed. The restructuring is expected to be completed by the end of 2016.

The plant biotechnology research portfolio will focus on high potential projects in herbicide tolerance and fungal resistant soybean. The project on polyunsaturated omega-3 fatty acids in canola seeds will also be continued. The yield and stress collaboration agreement regarding corn and soybean with Monsanto is not affected. Discovery and early development projects in yield and stress, including corn and soybean will be streamlined; rice yield as well as corn fungal resistance projects will be discontinued.

“We are confident that by refocusing our plant biotechnology portfolio, we will enable BASF to bring the most promising research projects to success. We will discontinue projects with extremely high technical challenges, which would require significant time and financial investment,” said Dr Harald Schwager, executive director’s board member, responsible for bioscience research, BASF.

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Axiall to sell window, door profiles business to OpenGate Capital

ATLANTA, GEORGIA: Axiall Corporation said that it will sell its window and door profiles business, a component of Royal Building Products, to OpenGate ...

Read more
L&T Hydrocarbon, McDermott collaborate for deepwater projects in India

MUMBAI, INDIA: L&T Hydrocarbon Engineering Limited (LTHE), a wholly-owned subsidiary of Larsen & Toubro (L&T) said that it has signed a lo ...

Read more
Bayer CEO to join Unilever as chairman

LEVERKUSEN, GERMANY: Bayer AG said that its CEO Dr Marijn Dekkers proposed to dissolve his contract, effective April. Werner Baumann, director in char ...

Read more
Quaker’s new board members; enhances steel, auto sector capability

CONSHOHOCKEN, US: Quaker Chemical Corporation said that Patricia Barron and Joseph Anderson Jr will retire upon completion of their current term as a ...

Read more
Clariant expands board of directors

MUTTENZ, SWITZERLAND: Clariant International AG said that it has proposed the election of Eveline Saupper, Claudia Suessmuth Dyckerhoff and Peter Stei ...

Read more
ICIG acquires Sandoz site in Frankfurt-Hochst

FRANKFURT, GERMANY: International Chemical Investors Group (ICIG) said that it has entered into an agreement with Novartis Group to acquire all the sh ...

Read more